Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, explains how controlling antibiotic use can impact Clostridium difficile rates.
Interview Transcript (slightly modified for readability)
“Actually, as we learn more about the control of C. difficile, it’s probably becoming more relevant to us that controlling the use or the misuse of antibiotics, will probably have the biggest impact on decreasing C. difficile [rates].
In studies that have already been published or are now coming out, when certain antimicrobials such as fluoroquinolones or cephalosporins are controlled or restricted, the rates of Clostridium difficile infection go down.
I think that’s a critically important component to a bundled approach of C. difficile.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512